Two anti-inflammatory drugs prevent COVID deaths

Home / Research Updates / Two anti-inflammatory drugs prevent COVID deaths

Two anti-inflammatory drugs prevent COVID deaths

Nature wades through the literature on the new coronavirus — and summarizes key papers as they appear.

A pharmacist displays a box of tocilizumab, which is used in the treatment of rheumatoid arthritis, France.

Tocilizumab is used to treat rheumatoid arthritis but has also shown promise in treating severe COVID-19.Credit: Alamy

14 January — Two anti-inflammatory drugs prevent COVID deaths 

Two drugs that dampen the body’s immune response can save the lives of people with severe COVID-19. 

Some people gravely ill with COVID-19 have tissue damage inflicted by their own immune response, and also show increased activity of immune-system molecules and cells regulated by a protein called IL-6. To study the effect of quashing IL-6 activity, Anthony Gordon of Imperial College London and his colleagues tested the drugs tocilizumab and sarilumab, which block the protein that immune cells use to detect IL-6 (A. C. Gordon et al. Preprint at medRxiv https://doi.org/fqgf; 2021).

The team gave the drugs to 803 adults with COVID-19 who were in intensive care and receiving organ support, such as ventilation or high-flow oxygen. Of these participants, 353 received tocilizumab, 48 received sarilumab and 402 received neither. The drug treatment reduced the death rate — from nearly 36% in the control group to 28% among those who received tocilizumab and 22% for sarilumab.

This email contains confidential information, some or all of which may be protected health information as defined by the federal Health Insurance Portability & Accountability Act (HIPAA) Privacy Rule. This transmission is intended for the exclusive use of the individual or entity to whom it is addressed and may contain information that is proprietary, privileged, confidential and/or exempt from disclosure under applicable law. If you are not the intended recipient (or an employee or agent responsible for delivering this email transmission to the intended recipient), you are hereby notified that any disclosure, dissemination, distribution or copying of this information is strictly prohibited and may be subject to legal restriction or sanction. If you have received this communication in error, please notify the sender immediately by return e-mail, and delete it permanently.

Leave a Reply

Your email address will not be published.